Incorporating alternative design clinical trials in network meta-analyses

Clinical Epidemiology

Volumn 7, Issue , 2014, Pages 29-35

  Thorlund, Kristian ^a,b,c   Druyts, Eric ^a,d   Toor, Kabirraaj ^a,e   Jansen, Jeroen P ^a,f   Mills, Edward J ^a,c  

^a Redwood Outcomes   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Department of Medicine ^*  (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adaptive; Golimumab; Indirect treatment comparison; Network meta analysis; Ulcerative colitis

Indexed keywords

GOLIMUMAB; PLACEBO;

ARTICLE; CLINICAL STUDY; DATA ANALYSIS; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG RESPONSE; EVIDENCE BASED MEDICINE; HUMAN; LOADING DRUG DOSE; META ANALYSIS; NETWORK META ANALYSIS; OUTCOME ASSESSMENT; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL (TOPIC); STUDY DESIGN; TREATMENT DURATION; ULCERATIVE COLITIS;

EID: 84919819816     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S70853     Document Type: Article

References (16)

1. Dias S, Sutton AJ, Ades AE, Welton NJ. Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Making. 2013;33(5):607-617.
2. Hoaglin DC, Hawkins N, Jansen JP, et al. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2. Value Health. 2011;14(4):429-437.
3. Mills EJ, Thorlund K, Ioannidis JP. Demystifying trial networks and network meta-analysis. BMJ. 2013;346:f2914.
4. Song F, Altman DG, Glenny AM, Deeks JJ. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ. 2003;326(7387):472.
5. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997;50(6):683-691.
6. Wells GA, Sultan SA, Chen L, Khan M, Coyle D. Indirect Evidence: Indirect Treatment Comparisons in Meta-Analysis. Ottawa, ON: Canadian Agency for Drugs and Technologies in Health; 2009.
7. Jansen JP, Fleurence R, Devine B, et al. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part1. Value Health. 2011;14(4):417-428.
8. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004;23(20):3105-3124.
9. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987;317(3):141-145.
10. Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005; 353(23):2462-2476.
11. Sandborn WJ, Feagan BG, Marano C, et al; PURSUIT-SC Study Group. Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology. 2014;146(1):85-95; quiz e14-e15.
12. Sandborn WJ, Feagan BG, Marano C, et al; PURSUIT-Maintenance Study Group. Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis. Gastroenterology. 2014;146(1):96-109. e1.
13. Sandborn WJ, van Assche G, Reinisch W, et al. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology. 2012;142(2):257-265. e1-e3.
14. Thorlund K, Druyts E, Mills EJ, Fedorak RN, Marshall JK. Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: an indirect treatment comparison meta-analysis. J Crohns Colitis. 2014;8(7):571-581.
15. Thorlund K. Incorporating adaptive clinical trials in network meta-analysis. Poster presented at: ISPOR 19th Annual Meeting; May 31-June 4, 2014; Montreal, Canada.
16. Stidham RW, Lee TC, Higgins PD, et al. Systematic review with network meta-analysis: the efficacy of anti-tumour necrosis factor-alpha agents for the treatment of ulcerative colitis. Aliment Pharmacol Ther. 2014;39(7):660-671.